AC Immune SA Debt to Equity

The latest debt-to-equity ratio for ACIU is 2.7. That is above the Healthcare sector average of 0.3. Investors often review this figure alongside AC Immune SA's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, ACIU currently prints 2.7 for debt-to-equity ratio, while the sector average sits near 0.3. That is roughly 796.5% above the sector mean. Large gaps often invite a closer look at AC Immune SA's growth, margins, and balance sheet.

A debt-to-equity ratio of 2.7 for AC Immune SA is not 'good' or 'bad' on its own. Compare it with the peer average (0.3) and with ACIU's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ACIU's debt-to-equity ratio (2.7), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AC Immune SA's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.